 | Up a level |
Everts-Graber, J; Reichenbach, Stephan; Gahl, Brigitta; Ziswiler, H R; Studer, U; Lehmann, T (2021). Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study. Bone, 144, p. 115830. Elsevier 10.1016/j.bone.2020.115830
Everts-Graber, J; Reichenbach, S.; Ziswiler, H R; Studer, U; Lehmann, T (2020). A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains. Journal of bone and mineral research, 35(7), pp. 1207-1215. Wiley-Blackwell 10.1002/jbmr.3962
Studer, U; Ruehe, B; Waldegg, G; Vajtai, I; Escher, R; Aeberli, D (2012). Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab. Rheumatology international, 32(5), pp. 1431-5. Berlin: Springer 10.1007/s00296-011-1915-x
